Cole Jason

Avg. Two Year Performance

No purchase track record
28% Avg. Sale Return
13% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)6%14%16%28%
Sale Success Rate17 of 3420 of 3415 of 3416 of 3413 of 34
Drugs » Biotechnology

Chief Strategy & Financial Off:

Holdings: 189.55K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

EVP,Corp Dev & General Counsel:

Holdings: 15.09K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--